These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9716317)

  • 1. Lack of beta adrenoceptor desensitization in brain following the dual noradrenaline and serotonin reuptake inhibitor venlafaxine.
    Nalepa I; Manier DH; Gillespie DD; Rossby SP; Schmidt DE; Sulser F
    Eur Neuropsychopharmacol; 1998 Aug; 8(3):227-32. PubMed ID: 9716317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serotonin/noradrenaline-link in brain. I. The role of noradrenaline and serotonin in the regulation of density and function of beta adrenoceptors and its alteration by desipramine.
    Manier DH; Gillespie DD; Sanders-Bush E; Sulser F
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):109-14. PubMed ID: 3031514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism.
    Dawson LA; Nguyen HQ; Geiger A
    Neuropharmacology; 1999 Aug; 38(8):1153-63. PubMed ID: 10462128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
    Jones CK; Eastwood BJ; Need AB; Shannon HE
    Neuropharmacology; 2006 Dec; 51(7-8):1172-80. PubMed ID: 17045620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1813-22. PubMed ID: 10884562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
    Weikop P; Kehr J; Scheel-Krüger J
    J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropharmacology of venlafaxine.
    Roseboom PH; Kalin NH
    Depress Anxiety; 2000; 12 Suppl 1():20-9. PubMed ID: 11098411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychopharmacological profile of venlafaxine].
    Bourin M
    Encephale; 1999 Jun; 25 Spec No 2():21-2; discussion 23-5. PubMed ID: 10434156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced signal transduction by 5-HT4 receptors after long-term venlafaxine treatment in rats.
    Vidal R; Valdizan EM; Vilaró MT; Pazos A; Castro E
    Br J Pharmacol; 2010 Oct; 161(3):695-706. PubMed ID: 20880406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
    Béïque JC; de Montigny C; Blier P; Debonnel G
    Synapse; 1999 Jun; 32(3):198-211. PubMed ID: 10340630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein.
    Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 1999 Sep; 48(3):345-54. PubMed ID: 10510145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine.
    Béïque JC; de Montigny C; Blier P; Debonnel G
    Br J Pharmacol; 1998 Oct; 125(3):526-32. PubMed ID: 9806336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of venlafaxine on pineal melatonin and noradrenaline in the male rat.
    Franklin M; Clement EM; Campling G; Cowen PJ
    J Psychopharmacol; 1998; 12(4):371-4. PubMed ID: 10065911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin-norepinephrine receptor interactions in the brain: implications for the pharmacology and pathophysiology of affective disorders.
    Sulser F
    J Clin Psychiatry; 1987 Mar; 48 Suppl():12-8. PubMed ID: 3029044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sertraline, a selective inhibitor of serotonin uptake, induces subsensitivity of beta-adrenoceptor system of rat brain.
    Koe BK; Koch SW; Lebel LA; Minor KW; Page MG
    Eur J Pharmacol; 1987 Sep; 141(2):187-94. PubMed ID: 2824215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of the responsiveness of cortical adrenergic receptors by chronic administration of the 5-hydroxytryptamine uptake inhibitor citalopram.
    Nalepa I; Vetulani J
    J Neurochem; 1993 Jun; 60(6):2029-35. PubMed ID: 8388032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ; Gobert A; Lejeune F; Newman-Tancredi A; Rivet JM; Auclair A; Peglion JL
    J Pharmacol Exp Ther; 2001 Aug; 298(2):565-80. PubMed ID: 11454918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test.
    Dhir A; Kulkarni SK
    Pharmacology; 2007; 80(4):239-43. PubMed ID: 17622775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of venlafaxine treatment on the behavioural and neurochemical changes in the olfactory bulbectomised rat.
    McGrath C; Norman TR
    Psychopharmacology (Berl); 1998 Apr; 136(4):394-401. PubMed ID: 9600586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.